‘In A Word, Complicated’ – AAM’s Burton Talks US Biosimilars

Biosimilars Council Chief Sees Improvement In US Market, But Says There Is Further To Go

 
• By Dave Wallace
  
A line in a tangled mess, complicated concept
Craig Burton explains the complications of the US biosimilars market • Source: Shutterstock

More from Biosimilars

More from Conferences